66 results
Algorithm for the Evaluation and Management of Sickle Cell Crises
Clinical Manifestations and Management

#Diagnosis #Management #Hematology #SickleCell
Algorithm for the ... Cell Crises Clinical ... Management #Diagnosis ... #Management #Hematology ... Manifestations #Workup #Algorithm
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
disorders • Diagnosis ... and Treatment Algorithm ... Syndrome #HES #Hematology ... #eosinophils #diagnosis ... #management #algorithm
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
and Management ... old, ~10,000 new cases ... only curative treatment ... #Management #treatment ... #hematology #oncology
Bronchiectasis: diagnosis and management 

Causes of localized -> diffuse bronchiectasis
Foreign body, Bronchial stenosis (tumor, .. ),
Bronchiectasis: diagnosis ... and management ... Causes of localized ... #workup #algorithm ... #pulmonary
Bradycardia Diagnostic and Management Algorithm

CONSIDER ETIOLOGY (not inclusive): 
 - STRUCTURAL: sick sinus, AV block, ischemia,
Bradycardia Diagnostic ... and Management ... Algorithm CONSIDER ... LIFE THREATENING CAUSES ... & TREATMENT -
The management of hypoxia in a patient undergoing a procedure has a variety of etiologies, but
The management of ... this instance, and ... recognize the cause ... #diagnosis #algorithm ... #management #treatment
Non-HCV infectious mixed cryoglobulinemia vasculitis - Diagnosis, causes and management - French Vasculitis Study Group

< 5%
cryoglobulinemia vasculitis - Diagnosis ... , causes and management ... neuropathy Treatment ... Cryoglobulinemia #Vasculitis #Rheumatology ... #Management
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... - Observe and ... Treat underlying cause ... #management #cardiology ... #algorithm
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
without other cause ... : 33% • Treatment ... CXR with pulmonary ... : No • Treatment ... #diagnosis #comparison
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... Currently, edoxaban and ... thrombosis; PE = pulmonary ... Anticoagulation #Management